Venus Remedies board recommends dividend

Venus Remedies Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 526953 | NSE: VENUSREM

21 Jun 2012 Evaluate

Venus Remedies has informed that the board of directors of the company at its meeting held on June 21, 2012, has recommended a dividend at the rate of 30% i.e. Rs. 3 per share for the financial year ended March 31, 2012 subject to approval of the same by shareholders at the annual general meeting.

The above information is a part of company's filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1853.50
Dr. Reddys Labs.	1145.25
Cipla	1359.75
Lupin	2047.20
Zydus Lifesciences	1105.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.